在动脉样硬化中,效细胞的机制
Li-Xia Shu1,2, Liu-Li Cao1,2, Xin Guo1,2
1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, China.
巨细胞通常在动脉样硬化 (AS) 中清除死细胞. 在先进的AS中,受损的细胞效应和CD47上调导致细胞积累,恶化疾病和死核扩张.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症性血管疾病,与心血管发病率和死亡率有关.
- 异常的细胞增殖和积累驱动AS斑块扩张,死核形成和破裂.
- 巨细胞在通过细胞分裂 (efferocytosis) 调节AS中发挥着关键作用,这是清除亡和亡细胞的过程.
研究的目的:
- 审查在动脉样硬化中效细胞的分子机制.
- 讨论AS进展过程中血清细胞如何变得受损.
- 探索效细胞的调节机制,以获得潜在的治疗见解.
主要方法:
- 关于分子机制的文献综述 在efferocytosis.
- 分析巨细胞功能的分析和早期和晚期AS的细胞分裂.
- 检查CD47在保护亡细胞免受细胞分裂中的作用.
主要成果:
- 在早期的AS中,巨细胞通过细胞分裂 (efferocytosis) 有效地清除亡细胞 (ACs),从而减缓疾病的进展.
- 在先进的AS中,巨细胞的效细胞化受损,导致AC去除延迟.
- 在AS斑块上升调的CD47抑制了ACs的巨细胞化,扩大了死核.
结论:
- 功能障碍的细胞效应和CD47上调是AS恶化的关键因素.
- 了解这些机制为新型AS治疗提供了潜在的目标.
- 恢复乙细胞形成可能是动脉样硬化的一种有希望的治疗策略.
更多相关视频
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
相关概念视频
Inflammation
Receptor-mediated Endocytosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
